U.S. Cord Blood Banking Services Market Size, Share, Growth and Profitability Analysis Forecasts

U.S. Cord Blood Banking Services Market Size ,Share ,Industry Growth Analysis And Forecast To 2025| Grand View Research, Inc

“The U.S. Cord Blood Banking (CBB) services market was valued over USD 17.2 billion in 2016 and is expected to reach over USD 49.09 billion at CAGR of around 12.2% during the forecast period.�

The U.S. cord blood banking market is expected to reach USD 49.1 billion by 2025, according to a new report by Grand View Research, Inc. Increasing awareness regarding long term benefits of cord blood storage, increasing number of service providers, reduction in cost involved in storage, and growing investment in public banking are the factors driving the market growth in the country.

The U.S. cord blood banking market captures a significant share of the global cord blood banking industry. Factors such as high adoption rate for advanced technologies, growing per capita income, and increasing number of storage service providers can be attributable to the largest market share.

Growing applications of cord blood in the treatment of several chronic disorders is expected to fuel the market.

Currently cord blood is approved for usage in around 80 diseases. These disease include degenerative disorders such as cancers, immunodeficiency related disorders, and bone marrow disorders. Growing prevalence of such diseases and need for effective therapeutic treatments are expected to boost the number of units stored. A large number of ongoing clinical trials in phase II, III, and IV are showing a potential growth opportunity in the near future.

Browse Details of Report @ www.grandviewresearch.com/industry-analysis/us-cord-blood-banking-servicesmarket

Follow Us:

Further Key Findings from the Report Suggest:  Private banking currently captures the largest revenue share and is expected to dominate the market throughout the forecast period 

Large number of parents opting for private banking, high prices involved in collection, transport and storage, and increasing number of these type of service provides are the prime factors expected to result in swift growth of the segment during the forecast period



Increasing awareness, high government investment, and efforts to store genetically diverse cord blood units are the factors expected to boost the segment growth of public banking



Cord blood captured the largest market share in 2016 over cord tissue and placenta. Relatively easy license acquisition, affordability, and ease of storage are the factors driving the segment share.



Key market players include California Cryobank Stem Cell Services LLC; Cord Blood America, Inc.; StemCyte, Inc.; Norton Healthcare, Inc.; Cryo-Cell International, Inc., and Lifeforce Cryobank Sciences Inc.

Grand View Research has segmented the U.S. cord blood banking market on the basis of blood bank type, component and state: Bank Type Outlook (Revenue, USD Billion, 2014 - 2025)  Private 

Public



Hybrid

Component 8Outlook (Revenue, USD Billion, 2014 - 2025)  Cord Blood 

Cord Tissue



Placenta

Regional Outlook (Revenue, USD Billion, 2014 - 2025)  Arizona 

California



Florida



Kentucky



New Jersey



Texas



Houston



Massachusetts

Browse Related Category Reports @ www.grandviewresearch.com/industry/biotechnology

Follow Us:

Table of Content of U.S. Cord Blood Banking Services Market Chapter 1 Research Methodology 1.1 Information procurement 1.2 Information or Data Analysis 1.2.1 Market Formulation & Validation 1.3 Region Wise Market Calculation 1.3.1 Region Wise Market: Base Estimates 1.3.2 Global Market: CAGR Calculation 1.4 List of Secondary Sources Chapter 2 Executive Summary 2.1 Market Snapshot Chapter 3 U.S. Cord Blood Banking Services Market Variables, Trends & Scope 3.1 Market segmentation & scope 3.1.1 Market Driver Analysis 3.1.1.1 Rising application of cord blood in treatment of chronic conditions 3.1.1.2 Rising focus of federal agencies to set up public banking units 3.1.1.3 Growing awareness regarding this treatment line 3.1.1.4 Increasing number of facilities across the region 3.1.2 Market Restraint Analysis 3.1.2.1 High cost and probability of non-usage 3.1.2.2 Market is highly driven by recommendation made by gynecologists 3.2 Penetration & growth prospect mapping 3.3 U.S. Cord Blood Banking Services Market -SWOT Analysis, by Factor (Political & Legal, Economic and Technological) 3.4 Industry Analysis -Porter’s 3.5 Opportunity Analysis 3.5.1 Opportunity Analysis: Placenta Storage 3.5.2 Opportunity Analysis: Potential usage of Cord Tissue and Placenta Tissue in Regenerative Medicine Using Stem Cells 3.6 Respository Analysis, By Bank Type, 2016 Chapter 4 U.S. Cord Blood Banking Services Market: Bank Type Estimates & Trend Analysis 4.1 U.S. cord blood banking services market: Bank type movement analysis

Follow Us:

4.2 Private banks 4.2.1 Market Estimates and Forecast, 2014 - 2025 (USD Billion) 4.2.2 Market Estimates and Forecast, 2014 - 2025 (No. of Units) 4.3 Public bank 4.3.1 Market Estimates and Forecast, 2014 - 2025 (USD Billion) 4.3.2 Market Estimates and Forecast, 2014 - 2025 (No. of Units) 4.4 Hybrid 4.4.1 Market Estimates and Forecast, 2014 - 2025 (USD Billion) 4.4.2 Market Estimates and Forecast, 2014 - 2025 (No. of Units) Chapter 5 U.S. Cord Blood Banking Services Market: Blood Component Estimates & Trend Analysis 5.1 U.S. cord blood banking services market: Blood component movement analysis 5.2 Cord blood 5.2.1 Market Estimates and Forecast, 2014 - 2025 (USD Billion) 5.2.2 Market Estimates and Forecast, 2014 - 2025 (No. of Units) 5.3 Cord tissue 5.3.1 Market Estimates and Forecast, 2014 - 2025 (USD Billion) 5.3.2 Market Estimates and Forecast, 2014 - 2025 (No. of Units) 5.4 Placenta 5.4.1 Market Estimates and Forecast, 2014 - 2025 (USD Billion) 5.4.2 Market Estimates and Forecast, 2014 - 2025 (No. of Units) Chapter 6 U.S. Cord Blood Banking Services Market: Regional Estimates & Trend Analysis, By Bank Type & Blood Component 6.1 U.S. 6.1.1 Market Estimates and Forecast, by Bank Type, 2014 - 2025 (USD Billion) 6.1.2 Market Estimates and Forecast, by Blood Componenet, 2014 - 2025 (USD Billion) 6.2 Arizona 6.2.1 Market Estimates and Forecast, by Bank Type, 2014 - 2025 (USD Billion) 6.2.2 Market Estimates and Forecast, by Blood Componenet, 2014 - 2025 (USD Billion) 6.3 California 6.3.1 Market Estimates and Forecast, by Bank Type, 2014 - 2025 (USD Billion) 6.3.2 Market Estimates and Forecast, by Blood Componenet, 2014 - 2025 (USD Billion) 6.4 Florida

Follow Us:

6.4.1 Market Estimates and Forecast, by Bank Type, 2014 - 2025 (USD Billion) 6.4.2 Market Estimates and Forecast, by Blood Componenet, 2014 - 2025 (USD Billion) 6.5 Kentucky 6.5.1 Market Estimates and Forecast, by Bank Type, 2014 - 2025 (USD Billion) 6.5.2 Market Estimates and Forecast, by Blood Componenet, 2014 - 2025 (USD Billion) 6.6 New Jersey 6.6.1 Market Estimates and Forecast, by Bank Type, 2014 - 2025 (USD Billion) 6.6.2 Market Estimates and Forecast, by Blood Componenet, 2014 - 2025 (USD Billion) 6.7 Texas 6.7.1 Market Estimates and Forecast, by Bank Type, 2014 - 2025 (USD Billion) 6.7.2 Market Estimates and Forecast, by Blood Componenet, 2014 - 2025 (USD Billion) 6.8 Houston 6.8.1 Market Estimates and Forecast, by Bank Type, 2014 - 2025 (USD Billion) 6.8.2 Market Estimates and Forecast, by Blood Componenet, 2014 - 2025 (USD Billion) 6.9 Massachusetts 6.9.1 Market Estimates and Forecast, by Bank Type, 2014 - 2025 (USD Billion) 6.9.2 Market Estimates and Forecast, by Blood Componenet, 2014 - 2025 (USD Billion) Chapter 7 Competitive Landscape 7.1 Strategy framework 7.2 Competitive Heat Map Analysis, by Region, 2016 7.3 Company Profiles 7.3.1 Cord Blood America, Inc. 7.3.1.1 Company overview 7.3.1.2 Financial performance 7.3.1.3 Product benchmarking 7.3.1.4 Strategic initiatives 7.3.2 California Cryobank Stem Cell Services, LLC. 7.3.2.1 Company overview 7.3.2.2 Financial performance 7.3.2.3 Product benchmarking 7.3.2.4 Strategic initiatives 7.3.3 StemCyte Inc.

Follow Us:

7.3.3.1 Company overview 7.3.3.2 Financial performance 7.3.3.3 Product benchmarking 7.3.3.4 Strategic initiatives 7.3.4 Cryo-Cell International, Inc. 7.3.4.1 Company overview 7.3.4.2 Financial performance 7.3.4.3 Product benchmarking 7.3.4.4 Strategic initiatives 7.3.5 Lifeforce Cryobank Sciences, Inc. 7.3.5.1 Company overview 7.3.5.2 Financial performance 7.3.5.3 Product benchmarking 7.3.6 Stem Cell Cryobank Inc. 7.3.6.1 Company overview 7.3.6.2 Financial performance 7.3.6.3 Product benchmarking 7.3.7 Norton Healthcare 7.3.7.1 Company overview 7.3.7.2 Financial performance 7.3.7.3 Product benchmarking 7.3.7.4 Strategic initiatives 7.3.8 Viacord Processing Laboratory (VPL) 7.3.8.1 Company overview 7.3.8.2 Financial performance 7.3.8.3 Product benchmarking 7.3.8.4 Strategic initiatives 7.3.9 New Jersey Cord Blood Bank 7.3.9.1 Company overview 7.3.9.2 Financial performance 7.3.9.3 Product benchmarking 7.3.9.4 Strategic initiatives

Follow Us:

7.3.10 Carter BloodCare 7.3.10.1 Company overview 7.3.10.2 Financial performance 7.3.10.3 Product benchmarking 7.3.10.4 Strategic initiatives 7.3.11 Americord Registry 7.3.11.1 Company overview 7.3.11.2 Financial performance 7.3.11.3 Product benchmarking 7.3.11.4 Strategic initiatives

About Us: Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415- 349-0058 Toll Free: 1-888- 202-9519 Email: sales@grandviewresearch.com For More Information: http://www.grandviewresearch.com

Follow Us:

Follow Us: